Hooman Djaladat
Overview
Explore the profile of Hooman Djaladat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
194
Citations
1222
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghoreifi A, Sheybaee Moghaddam F, Bronimann S, Gerald T, Helstrom E, Deol E, et al.
J Endourol
. 2025 Feb;
PMID: 40014477
To report the outcomes of minimally invasive (MIS) nephrectomy following immune checkpoint inhibitor (ICI) therapy. This multicenter retrospective cohort study included consecutive patients who underwent nephrectomy following ICI therapy at...
2.
Bhanvadia R, Bochner E, Popokh B, Taylor J, Franco A, Wu Z, et al.
Urol Oncol
. 2025 Feb;
PMID: 39956690
Background: The impact of cumulative smoking exposure (CSE) on oncologic outcomes for upper tract urothelial carcinoma (UTUC) remains understudied. We examined the effect of this factor on oncologic outcomes in...
3.
The impact of post-nephroureterectomy surgically induced chronic kidney disease on survival outcomes
Puri D, Meagher M, Wu Z, Franco A, Wang L, Margulis V, et al.
BJU Int
. 2024 Dec;
135(3):481-488.
PMID: 39663586
Objective: To investigate the prevalence, predictors and impact of surgically induced chronic kidney disease (CKD-S) on survival outcomes in patients with upper tract urothelial carcinoma (UTUC) following radical nephroureterectomy (RNU)....
4.
Antonelli L, Heidenreich A, Bagrodia A, Amini A, Baky F, Branger N, et al.
BJU Int
. 2024 Dec;
PMID: 39662898
Objectives: To reassess the role of primary retroperitoneal lymph node dissection (RPLND) in patients with marker-negative non-seminomatous germ cell tumour (NSGCT) clinical stage (CS) 2a, to explore results in patients...
5.
Tuderti G, Mastroianni R, Proietti F, Wu Z, Wang L, Franco A, et al.
World J Urol
. 2024 Nov;
42(1):641.
PMID: 39556201
No abstract available.
6.
Ghoreifi A, Sheybaee Moghaddam F, Mitra A, Khanna A, Singh A, Chavarriaga J, et al.
Eur Urol Focus
. 2024 Nov;
PMID: 39551650
Background And Objective: The feasibility and safety of a robotic approach for postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) in testicular cancer have been demonstrated, but data on long-term oncological outcomes...
7.
Alsyouf M, Ghoreifi A, Ashrafi A, Ladi-Seyedian S, Ahmadi H, Burg M, et al.
J Urol
. 2024 Oct;
213(1):70.
PMID: 39466635
No abstract available.
8.
Ghoreifi A, Djaladat H
Eur Urol Oncol
. 2024 Oct;
7(6):1551-1552.
PMID: 39455340
No abstract available.
9.
Bologna E, Licari L, Badani K, Razdan S, Psutka S, Ditonno F, et al.
J Robot Surg
. 2024 Oct;
18(1):369.
PMID: 39402405
Our aim was to investigate the perception and future expectations of Single-Port (SP) surgery among urology trainees in the United States. A 34-item online survey was distributed to urological residency...
10.
Tuderti G, Mastroianni R, Proietti F, Wu Z, Wang L, Franco A, et al.
World J Urol
. 2024 Oct;
42(1):575.
PMID: 39395052
Purpose: To assess the impact of neoadjuvant and adjuvant chemotherapy on survival outcomes, within a large multicenter cohort of Upper tract urothelial carcinoma patients treated with Nephroureterectomy. Methods: A multicenter...